Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Curevac N.V. (NQ: CVAC )

13.92 +0.16 (+1.16%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 8, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 289,963
Open 13.75
Bid (Size) 13.51 (1)
Ask (Size) 14.19 (1)
Prev. Close 13.76
Today's Range 13.47 - 14.31
52wk Range 12.39 - 75.68
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
BioNTech, Pfizer File For Clearance Over COVID-19 Vaccine Patent Dispute With CureVac
 
Via Benzinga
Pfizer Dives As CureVac Tees Up A Patent Suit Aimed At Its BioNTech-Partnered Covid Shot
The company isn't seeking an injunction, but wants "fair compensation." 
Via Investor's Business Daily

Performance

YTD
-60.51%
-60.51%
1 Month
-4.66%
-4.66%
3 Month
-9.32%
-9.32%
6 Month
-23.52%
-23.52%
1 Year
-77.61%
-77.61%

More News

Read More
Pfizer Dives As CureVac Tees Up A Patent Suit Aimed At Its BioNTech-Partnered Covid Shot
Via Investor's Business Daily
CureVac Files COVID-19 Vaccine Patent Infringement Lawsuit Against BioNTech
Via Benzinga
CureVac Files Patent Infringement Lawsuit in Germany Against BioNTech
From CureVac
Via AccessWire
Topics Intellectual Property Lawsuit
Exposures COVID-19 Financial Intellectual Property
Germany Inks COVID-19 Vaccine Deal With CureVac, GSK Until 2029
Via Benzinga
CureVac - GSK Start Dosing In Next-Gen COVID-19 Vaccine Candidate Trial
Via Benzinga
CureVac Announces Voting Results of General Meeting
From CureVac
Via AccessWire
Exposures COVID-19
CureVac Accelerates Oncology Strategy with Acquisition of Frame Cancer Therapeutics, Adding Novel Antigen Discovery Platform
From CureVac
Via AccessWire
CureVac Announces Changes of CDO - Myriam Mendila to Succeed Klaus Edvardsen
From CureVac
Via AccessWire
Billionaire Bill Gates Is Betting Against TSLA Stock. Here’s Where He’s Putting His Money Instead.
Via InvestorPlace
The Daily Biotech Pulse: Third FDA Rejection For Verrica's Skin Disease Drug, Assembly Bio Terminates Hepatitis B Virus Pact, Consistency Data For Valneva's Chikungunya Vaccine
Via Benzinga
CureVac Partners with myNEO to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine Development
From CureVac
Via AccessWire
Curevac Announces Financial Results For The First Quarter Of 2022 And Provides Business Update
From CureVac
Via AccessWire
Exposures COVID-19
The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates
Via Benzinga
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2021 and Provides Business Update
From CureVac
Via AccessWire
Exposures COVID-19
How To Attend CureVac Q4 2021 Earnings Conference Call
Via Benzinga
CureVac to Report Fourth Quarter and Full-Year 2021 Financial Results and Business Updates on April 28, 2022
From CureVac
Via AccessWire
The Daily Biotech Pulse: Ampio Falls On Knee Osteoarthritis Trial Update, AstraZeneca's COVID-19 Antibody Data, CureVac-GSK's Bivalent COVID-19 Vaccine Data
Via Benzinga
CureVac and GSK's Bivalent Second-Generation mRNA Vaccine Candidate Shown to be Highly Effective Against SARS-CoV-2 Variants in Preclinical Study
From CureVac
Via AccessWire
Exposures COVID-19
CureVac and GSK Enter into Pandemic Preparedness Contract with German Government
From CureVac
Via AccessWire
CureVac and GSK Start Clinical Development of Second-Generation COVID-19 Vaccine Candidate, CV2CoV
From CureVac
Via AccessWire
Exposures COVID-19
CureVac Establishes Fully-Owned Company Dedicated to Advancing The RNA Printer(R)
From CureVac
Via AccessWire
Exposures COVID-19
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.